Markers of insulin signaling such as Ir and Irs-2, shown to be altered in livers of humans and rodents of NAFLD [40,41], were also significantly lower in the livers of FFC-fed mice when compared to FFC + S–fed animals. Here, IRS2 is linked to metabolic dysfunction-associated steatotic liver disease.